Emil Kuriakose insider trades

Open-market stock purchases and sales by Emil Kuriakose, Chief Medical Officer at Terns Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 5, 2021.

Recent trades

DateStockTradeValue
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$1.3M
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$4.3M
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$2.3M
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$642K
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$791K
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$3.6M
May 5, 2026TERN Terns Pharmaceuticals, IncSold (not open market)$4.2M
Apr 1, 2026TERN Terns Pharmaceuticals, IncSold$49.7K
Jan 14, 2026TERN Terns Pharmaceuticals, IncBought (not open market)—
Jan 14, 2026TERN Terns Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026TERN Terns Pharmaceuticals, IncSold$7.9K
Jan 2, 2026TERN Terns Pharmaceuticals, IncSold$36.6K
Oct 1, 2025TERN Terns Pharmaceuticals, IncSold$7.4K

Companies traded

  • TERN Terns Pharmaceuticals, Inc: 7 sales, last May 5, 2026
  • CALA Calithera Biosciences, Inc: other filings, last Jan 23, 2023

Get free alerts when Emil Kuriakose files a new trade →